home / stock / vvos / vvos news

VVOS News and Press, Vivos Therapeutics Inc. From 08/10/21

Stock Information
Company Name: Vivos Therapeutics Inc.
Stock Symbol: VVOS
Market: NASDAQ
Website: vivoslife.com
Menu
VVOS VVOS Quote VVOS Short VVOS News VVOS Articles VVOS Message Board
Get VVOS Alerts

News, Short Squeeze, Breakout and More Instantly...
VVOS - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation in Q3 Virtual Investor Summit

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), will pa...
VVOS - Vivos Therapeutics to Participate at the Q3 Virtual Investor Summit

HIGHLANDS RANCH, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, includin...

VVOS - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Conference Call to Discuss Q2 2021 Financial Results

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), has sch...

VVOS - Vivos Therapeutics Schedules Second Quarter 2021 Financial Results Conference Call

Call Scheduled for Thursday, August 12, 2021 at 5:00 pm ET HIGHLANDS RANCH, Colo., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnost...
VVOS - Vivos Therapeutics: Reimagining Sleep

Vivos Therapeutics' mission is to rid the world of obstructive sleep apnea (OSA). Vivos is doing this by reimagining how OSA gets treated. While Vivos' competitors focus on treating OSA symptoms, Vivos is trying to cure OSA. They are doing this by selling a product that slowly res...

VVOS - InvestorNewsBreaks - Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Opening of Denver-Based State-of-the-Art International Training Center

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), today a...

VVOS - Vivos Therapeutics Opens State of the Art International Training Center In Denver

HIGHLANDS RANCH, Colo., July 29, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (the “Company” or “Vivos”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patien...
VVOS - CAN, DAO, NEGG among mid-day movers

Gainers: Bit Digital (BTBT) +51%.Infinity Pharmaceuticals (INFI) +46%.NanoVibronix (NAOV) +40%.Tilray (TLRY) +26%.Flora Growth Corp. (FLGC) +25%.Youdao (DAO) +24%.Grove (GRVI) +22%.Zhangmen Education (ZME) +23%.First High-School Education (FHS) +22%.Canaan (CAN) +21%.Losers: Hoegh LNG Partner...

VVOS - Infinity Pharmaceuticals, Grove leads healthcare gainers; Dyadic, EyeGate Pharmaceuticals among major losers

Gainers: Infinity Pharmaceuticals (INFI) +62%, Grove (GRVI) +26%, Shineco (TYHT) +24%, Tilray TLRY +22%, NeuroMetrix (NURO) +19%.Losers: Dyadic (DYAI) -14%, EyeGate Pharmaceuticals (EYEG) -13%, NanoViricides (NNVC) -13%, Myovant Sciences MYOV&...

VVOS - Vivos Therapeutics Inc.: New 52-Week Low Set Today (VVOS)

Shares of Vivos Therapeutics Inc. (NASDAQ:VVOS) traded at a new 52-week low today of $3.95. This new low was reached on above average trading volume as 973,000 shares traded hands, while the average 30-day volume is approximately 405,000 shares. Vivos Therapeutics Inc. (NASDAQ:VVOS) defi...
Previous 10 Next 10